Search - tctmd.com

Displaying 301 - 320 of 402

Sort: Relevancy | Date

Presentation TVT 2022

Cardiac Implants Tri-Ring for Functional Tricuspid Regurgitation: Technology Updates

Presenter: Mark Reisman

June 08, 2022

Presentation TVT 2022

The K-Clip Transcatheter Annuloplasty System

Presenter: Thomas Elie Modine

June 08, 2022

Presentation TVT 2022

Analysis of tricuspid valve morphologies which were deemed to be unsuitable for transcatheter tricuspid valve treatment

Presenter: Muhammed Gerçek

June 08, 2022

Presentation TVT 2022

Tricuspid Annulus Sparing Technologies: Spacers, Heterotopic Valves, and More

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Exercise Testing in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Presenter: Muhammed Gerçek

June 08, 2022

Presentation TVT 2022

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Presenter: Edwin Ho

June 08, 2022

Presentation TVT 2022

Massive Annular Dilatation: Current Technological Solutions and Limitations

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Presenter: Robert Smith

June 08, 2022

Presentation TVT 2022

Innovation in TTVI: Ongoing Challenges and Unmet Needs (Case-based)

Presenter: Neil Fam

June 08, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

Transcatheter Enhancers and Leaflet Extenders: Technology Concepts and Program Updates

Presenter: Howard Song

June 08, 2022

Presentation TVT 2022

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Presenter: Vinod H. Thourani

June 08, 2022

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Advertisement

Cardiac Implants Tri-Ring for Functional Tricuspid Regurgitation: Technology Updates

The K-Clip Transcatheter Annuloplasty System

Analysis of tricuspid valve morphologies which were deemed to be unsuitable for transcatheter tricuspid valve treatment

Tricuspid Annulus Sparing Technologies: Spacers, Heterotopic Valves, and More

Exercise Testing in Patients with Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Intervention

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Massive Annular Dilatation: Current Technological Solutions and Limitations

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Innovation in TTVI: Ongoing Challenges and Unmet Needs (Case-based)

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Transcatheter Enhancers and Leaflet Extenders: Technology Concepts and Program Updates

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Innovation in TMVr: Lessons Learned From the Surgeons

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content